Valuation: Ono Pharmaceutical Co., Ltd.

Market Cap 1,162B 7.27B 6.59B 6.09B 5.5B 10.36B 685B 10.72B 73.19B 29.02B 366B 27.28B 26.7B P/E 2027 *
15.5x
P/E 2028 * 18.1x
Enterprise Value 960B 6.01B 5.44B 5.03B 4.54B 8.56B 566B 8.86B 60.47B 23.98B 302B 22.54B 22.06B EV / Sales 2027 *
2.08x
EV / Sales 2028 * 2.03x
Free-Float
82.24%
Yield 2027 *
3.24%
Yield 2028 * 3.24%
1 day-0.58%
1 week+5.08%
Current month+9.57%
1 month+9.11%
3 months+1.73%
6 months-3.94%
Current year+13.79%
1 week 2,379
Extreme 2379
2,497.5
1 month 2,111.5
Extreme 2111.5
2,565.5
Current year 2,111.5
Extreme 2111.5
2,674.5
1 year 1,988
Extreme 1988
2,674.5
3 years 1,474
Extreme 1474
2,849
5 years 1,474
Extreme 1474
3,990
10 years 1,474
Extreme 1474
3,990
Manager TitleAgeSince
Chief Executive Officer 68 01/04/2024
Director of Finance/CFO - 01/04/2026
President 57 01/04/2024
Director TitleAgeSince
Chairman 68 01/04/2024
Director/Board Member 57 01/06/2020
Director/Board Member 77 26/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%+5.08%+21.21%-6.26% 7.27B
+1.26%+6.61%+40.79%+136.32% 1,286B
+0.79%+3.45%+45.84%+93.52% 688B
+0.20%+1.28%+26.97%+113.70% 521B
-0.44%+3.69%+41.45%+68.91% 386B
+0.55%+0.70%+59.02%+44.62% 364B
-0.12%+0.74%+28.39%+58.54% 302B
+0.37%+0.37%+3.33%+37.27% 287B
-0.30%+1.14%+38.29%+72.46% 252B
+0.08%+0.71%+34.44%+124.95% 208B
Average +0.18%+2.38%+33.97%+74.40% 430B
Weighted average by Cap. +0.54%+3.26%+37.67%+96.33%

Financials

2027 *2028 *
Net sales 463B 2.89B 2.62B 2.43B 2.19B 4.12B 273B 4.27B 29.13B 11.55B 146B 10.86B 10.63B 449B 2.81B 2.54B 2.35B 2.12B 4B 265B 4.14B 28.27B 11.21B 141B 10.53B 10.31B
Net income 75.38B 471M 427M 395M 357M 672M 44.45B 696M 4.75B 1.88B 23.75B 1.77B 1.73B 64.18B 401M 364M 336M 304M 572M 37.85B 592M 4.04B 1.6B 20.22B 1.51B 1.47B
Net Debt -202B -1.26B -1.14B -1.06B -955M -1.8B -119B -1.86B -12.72B -5.04B -63.62B -4.74B -4.64B -251B -1.57B -1.42B -1.32B -1.19B -2.24B -148B -2.32B -15.82B -6.27B -79.14B -5.9B -5.77B
Projected Income Statement - Annual - Ono Pharmaceutical Co., Ltd.
Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Employees
4,206
Date Price Change Volume
13/11/26 ¥2,472.00 -0.58% 1,199,000
12/11/26 ¥2,486.50 +2.58% 1,332,500
11/11/26 ¥2,424.00 -0.90% 1,206,300
10/11/26 ¥2,446.00 +0.55% 1,603,800
09/11/26 ¥2,432.50 +3.40% 1,497,600
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Ono Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,472.00JPY
Average target price
2,512.50JPY
Spread / Average Target
+1.64%
  1. Stock Market
  2. Stocks
  3. 4528 Stock